- Home
- NHIV vs RNAC Comparison
NHIV vs RNAC Comparison
Compare NHIV & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NHIV | RNAC |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.5M | 238.9M |
| IPO Year | 2026 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NHIV | RNAC |
|---|---|---|
| Price | $10.10 | $7.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 60.3K | ★ 125.8K |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.96 | $5.60 |
| 52 Week High | $10.10 | $12.47 |
Technical Indicators
Market Signals| Indicator | NHIV | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 75.25 | 36.72 |
| Support Level | $10.05 | $5.89 |
| Resistance Level | N/A | $7.66 |
| Average True Range (ATR) | 0.01 | 0.48 |
| MACD | -0.00 | -0.16 |
| Stochastic Oscillator | 100.00 | 8.86 |
Price Performance
Historical ComparisonAbout NHIV NewHold Investment Corp IV Class A Ordinary Shares
NewHold Investment Corp IV is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.